Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148M Sell
5,355,445
-4,718,173
-47% -$104M 5.28% 5
2026
Q1
$147M Buy
10,073,618
+684,829
+7% +$10.1M 7.54% 5
2025
Q4
$119M Buy
9,388,789
+2,121,950
+29% +$31.3M 5.92% 4
2025
Q3
$112M Buy
+7,266,839
New +$117M 6.43% 4

Other funds holding RXO

Finepoint Capital's RXO Position: Q2 2026 in Review

Finepoint Capital reduced its RXO (RXO) stake by 47% in Q2 2026, selling an estimated $104M and leaving 5,355,445 shares worth $148M. The position accounts for 5.28% of the portfolio, ranked #5.

Finepoint Capital first reported a position in RXO in Q3 2025 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Finepoint Capital held 5,355,445 shares of RXO worth $148M as of Q2 2026.
  • Finepoint Capital sold 4,718,173 RXO shares in Q2 2026, an estimated $104M.
  • RXO made up 5.28% of Finepoint Capital's portfolio in Q2 2026, its #5 holding.
  • Finepoint Capital first reported a position in RXO in Q3 2025 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Finepoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.